KRS Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Buy
5,210
+7
+0.1% +$7.15K 2.91% 6
2026
Q1
$4.79M Sell
5,203
-4
-0.1% -$4.05K 2.93% 5
2025
Q4
$5.6M Sell
5,207
-27
-0.5% -$25.8K 3.22% 5
2025
Q3
$3.99M Buy
5,234
+206
+4% +$153K 2.41% 6
2025
Q2
$3.92M Hold
5,028
2.62% 7
2025
Q1
$4.15M Buy
5,028
+122
+2% +$102K 3.3% 4
2024
Q4
$3.79M Buy
4,906
+156
+3% +$129K 2.68% 5
2024
Q3
$4.21M Sell
4,750
-20
-0.4% -$18K 3.07% 4
2024
Q2
$4.32M Buy
4,770
+16
+0.3% +$12.8K 3.23% 4
2024
Q1
$3.7M Sell
4,754
-235
-5% -$167K 2.98% 4
2023
Q4
$2.91M Buy
4,989
+201
+4% +$117K 2.71% 4
2023
Q3
$2.57M Buy
4,788
+57
+1% +$29.4K 2.74% 5
2023
Q2
$2.22M Buy
4,731
+22
+0.5% +$9.23K 2.22% 6
2023
Q1
$1.62M Buy
4,709
+443
+10% +$149K 1.82% 6
2022
Q4
$1.56M Buy
4,266
+293
+7% +$104K 2.13% 5
2022
Q3
$1.28M Buy
3,973
+861
+28% +$273K 1.77% 7
2022
Q2
$1.01M Buy
3,112
+27
+0.9% +$8.11K 1.44% 15
2022
Q1
$883K Buy
3,085
+2
+0.1% +$515 0.96% 26
2021
Q4
$851K Buy
+3,083
New +$782K 0.73% 31

Other funds holding LLY

KRS Capital Management's LLY Position: Q2 2026 in Review

KRS Capital Management increased its Eli Lilly (LLY) stake by 0.13% in Q2 2026, buying an estimated $7.15K and bringing the position to 5,210 shares worth $6.25M. The position accounts for 2.91% of the portfolio, ranked #6.

KRS Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KRS Capital Management held 5,210 shares of Eli Lilly worth $6.25M as of Q2 2026.
  • KRS Capital Management bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 2.91% of KRS Capital Management's portfolio in Q2 2026, its #6 holding.
  • KRS Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.